750332C

14:0 Cardiolipin (sodium salt)

1′,3′-bis[1,2-dimyristoyl-sn-glycero-3-phospho]-glycerol (sodium salt), chloroform

• Sinónimos: 1,1′,2,2′-tetratetradecanoyl cardiolipin (sodium salt); CL(1′-[14:0/14:0],3′-[14:0/14:0])
• Fórmula empírica (notación de Hill): C₆₅H₁₂₄Na₂O₁₇P₂
• Número de CAS: 63988-21-6
• Peso molecular: 1285.60
• UNSPSC Code: 51191904
• NACRES: NA.25

Propiedades

• assay: >99% (TLC)
• form: solution
• packaging: pkg of 1 × 2.5 mL (750332C-25mg); pkg of 2 × 4 mL (750332C-200mg)
• manufacturer/tradename: Avanti Research^™ - A Croda Brand 750332C
• concentration: 10 mg/mL (750332C-25mg); 25 mg/mL (750332C-200mg)
• lipid type: phospholipids; cardiolipins
• shipped in: dry ice
• storage temp.: −20°C

Descripción

General description

Cardiolipin, the mitochondrial-specific phospholipid, helps maintain mitochondrial function, membrane potential and structural support for the inner mitochondrial membrane and the proteins in it. Concentration and composition changes of cardiolipin have been implicated in pathological conditions including ischemia, hypothyroidism, aging, heart failure and cardioskeletal myopathy (Barth syndrome). Cardiolipin has also been shown as a signaling molecule in apoptosis.

Application

14:0 Cardiolipin (sodium salt) has been used for the mass spectrometry (MS) analysis to determine the structure of lipid A.

Packaging

5 mL Clear Glass Sealed Ampule (750332C-200mg)

5 mL Clear Glass Sealed Ampule (750332C-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Información de seguridad

• pictograms: GHS06,GHS08
• signalword: Danger
• hcodes: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• pcodes: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• target_organs: Central nervous system, Liver,Kidney
• wgk_germany: WGK 3